Company Overview
Proto Labs, Inc., together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. It offers manufacturing services, such as molding, computer numerical control machining, 3D printing, and sheet metal to developers, engineers, and supply chain teams. The company was incorporated in 1999 and is headquartered in Maple Plain, Minnesota.
Why Investors Should Care
Revenue has grown at a 15.1% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.32.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $533.13M (+6.4% YoY); net profit $21.24M.
- Trailing 12 Months Year-on-year growth — revenue +10.6%, earnings +105.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 15.1%, profit CAGR 4.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.07% |
| 1 Year: | 10.60% |
Compounded Profit Growth
| 5 Years: | 4.52% |
| 1 Year: | 105.60% |
Stock Price Performance
| 1 Year: | +65.53% |
| 6 Months: | +42.03% |
| 3 Months: | +12.11% |
| 1 Month: | -7.36% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)50.72 · Neutral
P/E of 64.63 is above the sector median of 27.38 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 15.1% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 64.6.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PRLB Proto Labs, Inc. R2KR3K | 81.44 | 64.63 | $1.95B | 0.00% | 3.61% | 4.49% | 15.07% | 4.52% |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 147.95 | -134.50 | $1.12T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 813.94 | 35.05 | $374.15B | 0.76% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 337.12 | 39.85 | $349.78B | 0.50% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 200.79 | 35.41 | $270.62B | 1.31% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 941.95 | 26.98 | $250.87B | 0.20% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 693.53 | 39.29 | $187.33B | 1.05% | 12.53% | 18.35% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 291.88 | 23.83 | $173.40B | 1.92% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 212.25 | 76.08 | $167.63B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit | 24.85M | 25.95M | 29.02M | 32.68M | 33.08M | 35.25M | 37.55M | 40.33M | 39.65M | 42.25M | 44.73M | 45.27M | 46.37M | 49.31M | 57.91M | 59.21M | 62.40M | 58.86M | 60.24M | 59.62M | 58.10M | 52.46M | 54.64M | 55.33M | 56.62M | 55.32M | 55.80M | 57.42M | 53.63M | 53.78M | 53.12M | 59.28M | 57.47M | 56.55M | 57.23M | 55.70M | 59.77M | 61.29M | 63.59M | 69.34M |
| Operating Income | 12.63M | 13.40M | 14.45M | 15.97M | 15.44M | 15.84M | 17.35M | 17.40M | 15.14M | 14.85M | 16.94M | 17.68M | 16.40M | 19.37M | 21.73M | 21.98M | 25.03M | 19.45M | 19.57M | 21.27M | 16.82M | 14.35M | 17.67M | 4.26M | 16.10M | 6.93M | 7.89M | 5.20M | 6.06M | 3.75M | 5.61M | 10.41M | 6.83M | 6.00M | 8.58M | 4.53M | 4.97M | 8.81M | 9.84M | 11.36M |
| Net Income | 8.61M | 8.87M | 10.10M | 10.96M | 10.38M | 10.45M | 11.69M | 12.38M | 10.66M | 10.69M | 11.98M | 12.20M | 12.09M | 13.22M | 18.05M | 18.31M | 20.94M | 15.51M | 16.17M | 16.79M | 13.98M | 12.61M | 14.70M | 3.71M | 12.91M | 4.83M | 5.09M | 2.56M | 3.95M | 2.66M | -383.00K | 7.95M | 5.27M | 4.54M | 7.19M | 3.60M | 4.43M | 7.22M | 8.11M | 9.15M |
| Diluted EPS | 0.33 | 0.34 | 0.39 | 0.42 | 0.40 | 0.40 | 0.44 | 0.47 | 0.40 | 0.40 | 0.45 | 0.46 | 0.45 | 0.49 | 0.66 | 0.67 | 0.77 | 0.57 | 0.60 | 0.62 | 0.52 | 0.47 | 0.55 | 0.13 | 0.47 | 0.17 | 0.19 | 0.09 | 0.14 | 0.10 | -0.01 | 0.31 | 0.20 | 0.18 | 0.29 | 0.15 | 0.18 | 0.30 | 0.33 | 0.37 |
| R&D Expense | 2.75M | 3.03M | 3.46M | 3.91M | 4.55M | 4.31M | 4.40M | 4.76M | 5.32M | 5.82M | 5.98M | 5.82M | 6.08M | 5.88M | 6.67M | 7.03M | 7.46M | 8.01M | 8.17M | 8.36M | 8.99M | 8.65M | 7.92M | 12.18M | 11.06M | 10.61M | 10.56M | 9.45M | 9.31M | 10.68M | 9.87M | 10.11M | 11.17M | 10.66M | 9.77M | 10.61M | 11.17M | 10.71M | 10.54M | 10.79M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 64.92M | 98.94M | 125.99M | 163.11M | 209.58M | 264.11M | 298.06M | 344.49M | 445.60M | 458.73M | 434.39M | 488.10M | 488.40M | 503.88M | 500.89M | 533.13M |
| Gross Profit | 39.48M | 59.62M | 76.14M | 101.70M | 128.40M | 154.40M | 166.94M | 193.84M | 238.68M | 235.29M | 217.83M | 222.69M | 215.47M | 221.99M | 223.20M | 237.14M |
| Operating Income | 15.93M | 26.87M | 34.95M | 51.30M | 60.53M | 67.15M | 61.77M | 72.23M | 88.90M | 79.86M | 59.84M | 40.34M | -97.98M | 28.17M | 19.91M | 25.11M |
| Net Income | 10.95M | 17.97M | 24.02M | 35.28M | 41.63M | 46.51M | 42.71M | 51.78M | 76.59M | 63.66M | 50.87M | 33.37M | -103.46M | 17.22M | 16.59M | 21.24M |
| Diluted EPS | 0.34 | 0.67 | 0.98 | 1.36 | 1.60 | 1.77 | 1.61 | 1.93 | 2.81 | 2.35 | 1.89 | 1.21 | -3.77 | 0.66 | 0.66 | 0.88 |
| R&D Expense | 4.28M | 5.22M | 9.14M | 11.86M | 16.61M | 18.35M | 22.39M | 23.56M | 28.73M | 32.69M | 36.94M | 44.24M | 38.22M | 40.13M | 41.30M | 42.81M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 62.33M | 172.72M | 230.18M | 287.03M | 361.04M | 414.24M | 518.74M | 618.99M | 673.67M | 744.20M | 928.58M | 802.17M | 772.35M | 743.51M | 763.41M |
| Total Equity | -43.04M | -36.09M | -20.24M | 156.70M | 211.64M | 265.54M | 327.64M | 379.83M | 461.21M | 541.50M | 585.79M | 644.36M | 828.49M | 697.65M | 695.29M | 670.15M | 673.93M |
| Cash & Equivalents | 2.70M | 6.10M | 8.13M | 36.76M | 43.04M | 43.33M | 47.65M | 68.80M | 36.71M | 85.05M | 125.22M | 127.60M | 65.93M | 56.56M | 83.79M | 89.07M | 110.83M |
| Long Term Debt | - | - | 629.00K | - | 363.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | 16.02M | 18.53M | 21.49M | 33.39M | 34.41M | 57.52M | 77.49M | 87.88M | 99.85M | 100.09M | 104.52M | 77.06M | 73.36M | 89.48M |
| Current Liabilities | - | - | 9.94M | 11.54M | 13.66M | 18.76M | 26.26M | 23.43M | 43.76M | 52.73M | 47.58M | 50.25M | 54.90M | 71.58M | 49.68M | 53.27M | 67.00M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.01M | 23.54M | 25.31M | - | - | 64.10M | 77.50M | 81.75M | 122.93M | 116.05M | 106.97M | 55.24M | 62.08M | 73.27M | 77.83M | 74.50M |
| Investing Cash Flow | -6.04M | -18.50M | -79.25M | - | - | -63.59M | -60.76M | -123.97M | -63.28M | -44.30M | -95.47M | -94.66M | -43.09M | -4.55M | -13.58M | -13.41M |
| Financing Cash Flow | -4.23M | -2.85M | 82.79M | - | - | 4.70M | 5.32M | 9.19M | -10.44M | -31.62M | -10.73M | -22.20M | -27.92M | -41.86M | -58.55M | -40.37M |
| Capital Expenditure | -7.07M | -19.00M | -17.40M | -18.75M | -43.51M | -44.36M | -33.62M | -32.63M | -87.10M | -62.23M | -47.01M | -34.21M | -21.69M | -28.12M | -9.17M | -14.84M |
| Free Cash Flow | 6.94M | 4.53M | 7.91M | - | - | 19.73M | 43.88M | 49.11M | 35.83M | 53.82M | 59.96M | 21.03M | 40.39M | 45.16M | 68.66M | 59.66M |
| Share Buybacks | - | - | - | - | - | - | - | 4.41M | 12.23M | 33.52M | 14.69M | 23.28M | 29.66M | 43.95M | 60.28M | 42.96M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 60.8% | 60.3% | 60.4% | 62.4% | 61.3% | 58.5% | 56.0% | 56.3% | 53.6% | 51.3% | 50.1% | 45.6% | 44.1% | 44.1% | 44.6% | 44.5% |
| Operating Margin % | 24.5% | 27.2% | 27.7% | 31.5% | 28.9% | 25.4% | 20.7% | 21.0% | 20.0% | 17.4% | 13.8% | 8.3% | -20.1% | 5.6% | 4.0% | 4.7% |
| Net Margin % | 16.9% | 18.2% | 19.1% | 21.6% | 19.9% | 17.6% | 14.3% | 15.0% | 17.2% | 13.9% | 11.7% | 6.8% | -21.2% | 3.4% | 3.3% | 4.0% |
| ROE % | -30.3% | -88.8% | 15.3% | 16.7% | 15.7% | 14.2% | 11.2% | 11.2% | 14.1% | 10.9% | 7.9% | 4.0% | -14.8% | 2.5% | 2.5% | 3.2% |
| ROCE % | - | 51.3% | 21.7% | 23.7% | 22.6% | 20.1% | 15.8% | 15.2% | 15.7% | 12.8% | 8.6% | 4.6% | -13.4% | 3.9% | 2.9% | 3.6% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 16.29% | 3.90M | $310.68M |
| 2 | Disciplined Growth Investors, Inc. | 9.95% | 2.38M | $189.82M |
| 3 | Vanguard Portfolio Management LLC | 6.69% | 1.60M | $127.57M |
| 4 | Dimensional Fund Advisors LP | 4.82% | 1.15M | $91.88M |
| 5 | State Street Corporation | 4.76% | 1.14M | $90.78M |
| 6 | Vanguard Capital Management LLC | 4.41% | 1.05M | $84.10M |
| 7 | American Capital Management, Inc. | 2.59% | 619.85K | $49.43M |
| 8 | Geode Capital Management, LLC | 2.57% | 614.03K | $48.96M |
| 9 | Renaissance Technologies, LLC | 1.96% | 469.25K | $37.42M |
| 10 | Prudential Financial, Inc. | 1.91% | 457.81K | $36.51M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PRLB
Are Industrial Products Stocks Lagging Proto Labs (PRLB) This Year? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPOXNmWnZiTW9XdW1SRlctSnJNaGNhbDM5bF90Q0p5NmdTdlJJRkJEWE02QXVjbkZZV2otZDR3SmJ3WWpHTUtwV1VXUTlYZGZNM3JQRFEwRkVxSkl1VmZHU24yQ1lUdG1GcWRHaFlldG1pejIxRG1TVHhORngtSDlFWGxxUEppekpiME5JLW…
Proto Labs (PRLB) Climbed, But What Is Driving Attention Now? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPcGpVQl8zSER3SUJpNXJVRE9XeDFyU3Etb1E5MG5KVC1VV19wQjh0UmtESkZ6TDZwU056Z2ZrNTVQUzhCay1oTmxEZ2RhZ3l6cTNUcEJPSGNRT2hESFRPb1VHOTB2UHlGcy1mUUoxQ2lXb2FHcnlvejU2cmhpZDFTQVB2MGJTNGNiSUh2Ml…
(PRLB) and the Role of Price-Sensitive Allocations - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOUEtiYjRveXdwWEY0ZE9TVXFIclAwUVZaS01IdU95S0V3a055Y1hfUUlDUlFVV09iWVVoUER1MjhpTHAwdUxFWVR2TG5fYlFtSlRFamNzeFRIZzB6N2pVVF9wdUNzTmdFT2ZZblh4WkU4ZmxQd25KSVR5cDZ2WmRLZEpNYjNVSUYya21XZz…
PRLB - Proto Labs Inc Stock Price and Quote - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE1pMDdXQTRLd1lJNk9xWjFFQnV2YWpDa2FOdmV4cmR1cEJnLVNSRHliNFZ6S2NIM0xKbkVsWnUyZWI2dXNUV0E?oc=5" target="_blank">PRLB - Proto Labs Inc Stock Price and Quote</a> <font color="…
Protolabs' incoming operations chief led 1,300 workers across five plants - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQWlJwTkVnR2tNWDhUYmkxbjNUZzlfeEExMnAtcWxBdDdsZXNkbGJRZm1MdGdVNm1wQ3BJbWdVZ0Y5TktmR0hkRGlEVDJmWGZTamFGVXg4bW11azlBYmxwdWR0c01LcWhQNVdfU0lvaFU2TFlON0VGMWFfb0Q5d08xcXVrVXdzZjZXaTdSUW…
The Bull Case For Proto Labs (PRLB) Could Change Following COO Appointment And Innovation Accolade - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNbzQ3cUVNR1dDWDFSZ3RQVnItWFZpV29tcC1wc0hQalZBTFN4RmdVV1ZwTkJaMnRXSmg0Y2t3b0gtU0FlUGhvUlVWVG9UZTVxeHl4by1jWFFCMGRHMDhxdzVRSXJwNTBuckpUZUJSX0xudUtkU2ozNTE2NkYtUmJMcUUtTDVQUXFHTHVXTl…
PRLB — Frequently Asked Questions
What is the current share price of Proto Labs, Inc. (PRLB)?
As of 2026-09-07 16:24 PDT, Proto Labs, Inc. (PRLB) trades at $81.44 on NYSE. Its 52-week range is $46.81 to $92.32.
What is the market capitalisation of PRLB?
Proto Labs, Inc. (PRLB) has a market capitalisation of $1.95B on NYSE.
What is the P/E ratio of PRLB?
PRLB trades at a trailing price-to-earnings (P/E) ratio of 64.63. The industry average P/E is 27.38. Its price-to-book (P/B) ratio is 3.07.
What is the return on equity (ROE) of PRLB?
PRLB has a return on equity (ROE) of 4.49%. Its return on capital employed (ROCE) is 3.61%.
Is PRLB a good stock to buy?
This page provides a data-driven analysis of Proto Labs, Inc. (PRLB), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.